- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Glenmark Launches Vancomycin Injection In US, Targets Rs 37.9 Million Market | 2 | The Free Press Journal | ||
| 12.05. | Glenmark Pharmaceuticals Ltd slips for fifth straight session | 2 | capitalmarket.com | ||
| 23.04. | Glenmark Pharmaceuticals Ltd spurts 3.28% | 2 | capitalmarket.com | ||
| 09.04. | Glenmark Gets FDA Approval for Bioequivalent Progesterone Vaginal Insert | 6 | Contract Pharma | ||
| 09.04. | Glenmark Pharmaceuticals Receives U.S. FDA Approval for Progesterone Vaginal Inserts, 100 mg | 899 | PR Newswire | ELMWOOD PARK, N.J., April 9, 2026 /PRNewswire/ -- Glenmark Pharmaceuticals Limited (Glenmark) has received final approval from the United States Food & Drug Administration... ► Artikel lesen | |
| 09.04. | Glenmark Pharma gets USFDA nod for Progesterone Vaginal Inserts | 5 | capitalmarket.com | ||
| 02.04. | Glenmark goes direct with new US Ryaltris marketing plan as it drops partner model | 5 | FiercePharma | ||
| 01.04. | Glenmark Pharmaceuticals Announces Strategic Shift to Direct Commercialization and Distribution of RYALTRIS in the U.S., Significantly Expanding Its Innovative Portfolio | 167 | PR Newswire | RYALTRIS® is Glenmark's first innovative product introduced into the U.S. market
ELMWOOD PARK, N.J., April 1, 2026 /PRNewswire/ -- Glenmark Pharmaceuticals Inc.... ► Artikel lesen | |
| GLENMARK PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 31.03. | Glenmark Pharmaceuticals Canada Inc. Launches Men's GLN-Minoxidil 5% w/w Topical Aerosol Foam in Canadian Retail | 363 | PR Newswire | GLN-Minoxidil Men's 5% Foam is a topical treatment formulated with 5% minoxidil, a widely used and clinically established ingredient for supporting hair regrowth in men. The fast-drying, unscented aerosol... ► Artikel lesen | |
| 24.03. | Glenmark Pharma may outperform amid market correction; technicals turn positive: Ruchit Jain | 4 | Times of India | ||
| 21.03. | Glenmark Pharma launches GLIPIQ (semaglutide) in India for Type 2 Diabetes at lower cost | 3 | capitalmarket.com | ||
| 19.03. | Glenmark secures USFDA nod for OTC Nasal Spray; launches Generic Milnacipran tablets in US | 3 | capitalmarket.com | ||
| 16.03. | Glenmark Pharma gains as US arm to launch Potassium Phosphates Injection | 2 | capitalmarket.com | ||
| 05.03. | FDA gives Glenmark thumbs up for first 'true' generic version of GSK's asthma inhaler Flovent | 4 | FiercePharma | ||
| 04.03. | Glenmark Gets FDA Nod for Fluticasone Propionate Inhalation Generic | 2 | Contract Pharma | ||
| 04.03. | Glenmark Pharmaceuticals: Glenmark Specialty SA Receives U.S. FDA Approval for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation, with 180-Day Competitive Generic Therapy Exclusivity | 264 | PR Newswire | ELMWOOD PARK, N.J., March 4, 2026 /PRNewswire/ -- Glenmark Specialty SA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S.... ► Artikel lesen | |
| 04.03. | Glenmark Pharma secures USFDA nod for Fluticasone Propionate Inhalation Aerosol | 7 | capitalmarket.com | ||
| 04.03. | Glenmark Wins US FDA Approval For Inhalation Therapy Medicine With 180 Day Generic Exclusivity | 4 | The Free Press Journal | ||
| 27.02. | Glenmark Pharma's USA arm to market Sodium Phosphate injection in April 2026 | 3 | capitalmarket.com | ||
| 26.02. | Glenmark Pharmaceuticals Ltd gains for third straight session | 2 | capitalmarket.com |
1 2 Weiter >>
36 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SINOPHARM | 1,980 | 0,00 % | Sinopharm expands its international presence | ||
| CSPC PHARMA | 0,805 | -1,20 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - HIGHLY SELECTIVE KAT6 INHIBITOR (SYH2095 TABLETS) OBTAINS CLINICAL TRIAL APPROVAL IN CHINA | ||
| WUXI BIOLOGICS | 3,570 | -0,70 % | WUXI BIO (02269): FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON WEDNESDAY, JUNE 10, 2026 | ||
| SHANGHAI FOSUN PHARMACEUTICAL | 1,906 | 0,00 % | Fosun Pharma, AriBio Sign Exclusive Global Option Agreement | ||
| GEDEON RICHTER | 34,300 | +0,88 % | Gedeon Richter Plc.: Transactions with Treasury Shares | ||
| DR REDDYS | 11,500 | 0,00 % | DR REDDYS LABORATORIES LTD - 6-K, Report of foreign issuer | ||
| ASPEN PHARMACARE | 7,000 | -2,10 % | ASPEN PHARMACARE HOLDINGS LIMITED - Dealing in Securities by a Director and Prescribed Officer | ||
| SHANGHAI PHARMACEUTICALS | 1,340 | +3,88 % | Dividendenbekanntmachungen (29.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADWAYS INC JP3121970002 6,35 JPY 0,0344 EUR AGC INC JP3112000009 105 JPY 0,5701 EUR AMERICAN TOWER CORPORATION US03027X1000 1... ► Artikel lesen | |
| LUYE PHARMA | 0,248 | +2,48 % | LUYE PHARMA (02186): ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2025 | ||
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP | 0,113 | 0,00 % | SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT SHARE REPURCHASE | ||
| CHINA RESOURCES PHARMACEUTICAL | 0,510 | 0,00 % | CHINARES PHARMA (03320): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025 (UPDATED) | ||
| HANSOH PHARMACEUTICAL | 3,681 | -1,37 % | HANSOH PHARMA (03692): CHANGES OF JOINT COMPANY SECRETARY, AUTHORIZED REPRESENTATIVE AND PROCESS AGENT | ||
| CHINA SHINEWAY PHARMACEUTICAL GROUP | 0,960 | +2,67 % | SHINEWAY PHARM 1Q26 Revenue RMB624 million, Down 18% YoY | ||
| KALBE FARMA | 0,035 | -1,41 % | KLBF profit rises 13% in 2025, prepares IDR 500 billion buyback: Strong export lifts KLBF's net profit 13% to ... | ||
| BAYER | 38,520 | +1,82 % | Bayer: Richtungsentscheidung rückt näher | Die Bayer-Aktie steht derzeit im Zeichen einer möglichen Richtungsentscheidung. Im Fokus stehen dabei zentrale technische Marken und die gleitenden Durchschnitte Den vollständigen Artikel lesen ... ► Artikel lesen |
GLENMARK PHARMACEUTICALS LTD gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLENMARK PHARMACEUTICALS LTD finden Sie auf Wallstreet Online.